Literature DB >> 9391534

The ileal neobladder to the female urethra.

R E Hautmann1.   

Abstract

In the author's opinion, in the properly selected woman undergoing radical cystectomy for transitional cell carcinoma of the bladder, the ileal neobladder to the female urethra is a viable option. Ten years of experience with 23 patients have led to a nerve and urethral support cystectomy technique with the ileal neobladder anastomosed to the proximal urethra. Even then, however, retention in 20% of patients rather than the expected incontinence is the critical issue. Incontinence has never been a problem. The advent of orthotopic lower urinary reconstruction in women is a major achievement in the evolution of urinary diversion. With our increasing understanding of the continence mechanism in women and with increasing evidence that the female urethra can be safely preserved after cystectomy, orthotopic lower urinary tract reconstruction by the ileal neobladder can now be offered safely not only to men but also to women undergoing cystectomy with superb functional results.

Entities:  

Mesh:

Year:  1997        PMID: 9391534     DOI: 10.1016/s0094-0143(05)70423-7

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  3 in total

1.  [Implantation of the AMS 800 artificial sphincter system in a woman via a paraurethral access].

Authors:  V Schick
Journal:  Urologe A       Date:  2005-07       Impact factor: 0.639

2.  Ileal orthotopic neobladder in women: the first experiences from Turkey and our modifications.

Authors:  Z Bayraktar; G Sevin; G Gurbuz; A I Taşci
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

3.  Sacrocolpopexy with polypropylene tape as valuable surgical modification during cystectomy with orthotopic ileal bladder: functional results.

Authors:  Marcin Życzkowski; Bartosz Muskała; Zbigniew Kaletka; Piotr Bryniarski; Krzysztof Nowakowski; Rafał Bogacki; Andrzej Paradysz
Journal:  Biomed Res Int       Date:  2015-02-19       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.